Formula Growth’s Houlihan Lokey HLI Stock Holding History

Formula Growth’s Portfolio HLI Stock Details HLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-110,000	Closed	-$4.05M	–	147
2018 Q4	$4.05M	Buy	+110,000	New	+$4.48M	0.67%	42

Other funds holding HLI

OCU

ORIX Corporation USA Dallas, Texas $2.31M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Formula Growth's HLI Position: Q1 2019 in Review

Formula Growth sold out of Houlihan Lokey (HLI) in Q1 2019, closing a stake of 110,000 shares — an estimated $4.05M sold.

Formula Growth first reported a position in HLI in Q4 2018 and held it in 1 quarter. The position peaked at $4.05M in Q4 2018. 168 funds tracked by Wall St. Rank hold HLI as of Q1 2019.

Formula Growth reported no remaining Houlihan Lokey position as of Q1 2019 after selling out during the quarter.
Formula Growth sold 110,000 Houlihan Lokey shares in Q1 2019, an estimated $4.05M.
Formula Growth first reported a position in Houlihan Lokey in Q4 2018 and held it in 1 quarter.
Formula Growth's Houlihan Lokey position peaked at $4.05M in Q4 2018.
168 funds tracked by Wall St. Rank held Houlihan Lokey as of Q1 2019.

Based on Formula Growth's 13F filing for Q1 2019, filed 14 May 2019.